Carmel Capital Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-423
Closed -$26.6K – 470
2023
Q3
$26.6K Buy
423
+162
+62% +$10.1K 0.01% 315
2023
Q2
$14.8K Sell
261
-1,755
-87% -$97.4K 0.01% 267
2023
Q1
$117K Sell
2,016
-1,663
-45% -$112K 0.07% 174
2022
Q4
$266K Sell
3,679
-151
-4% -$10.8K 0.18% 109
2022
Q3
$233K Hold
3,830
– – 0.23% 105
2022
Q2
$240K Hold
3,830
– – 0.22% 98
2022
Q1
$269K Sell
3,830
-334
-8% -$22.6K 0.22% 91
2021
Q4
$260K Buy
+4,164
New +$261K 0.19% 96

Other funds holding MET

Carmel Capital Partners's MET Position: Q4 2023 in Review

Carmel Capital Partners sold out of MetLife (MET) in Q4 2023, closing a stake of 423 shares — an estimated $26.6K sold.

Carmel Capital Partners first reported a position in MET in Q4 2021 and held it in 8 quarters. The position peaked at $269K in Q1 2022. 1,262 funds tracked by Wall St. Rank hold MET as of Q4 2023.

  • Carmel Capital Partners reported no remaining MetLife position as of Q4 2023 after selling out during the quarter.
  • Carmel Capital Partners sold 423 MetLife shares in Q4 2023, an estimated $26.6K.
  • Carmel Capital Partners first reported a position in MetLife in Q4 2021 and held it in 8 quarters.
  • Carmel Capital Partners's MetLife position peaked at $269K in Q1 2022.
  • 1,262 funds tracked by Wall St. Rank held MetLife as of Q4 2023.

Based on Carmel Capital Partners's 13F filing for Q4 2023, filed 1 Feb 2024.